Archives: Communications

  • Cherrystone Chairman, Stephen Schweich, featured on FPA New England Podcast

    August 28, 2025 On August 15, 2025, Stephen Schweich was interviewed by Michael Connaughton of the Financial Planning Association of New England for a podcast intended for the group’s financial planning advisors called “The Wicked Pissah Podcast”. Following is a transcript of the interview, which has been edited slightly to make it more readable. Listen…

  • Lenoss Medical closes Series A funding round

    Lenoss Medical completed a $4M Series A funding round led by Xcellerant Ventures in late December 2023. The Company believes that this investment will allow them to fully launch by the end of 2024 and reach cash flow positive in 2025. Read the full story here.

  • Cherrystone welcomes 3 new portfolio companies in early 2024

    Cherrystone members have invested in three new companies in 2024, including Flourish Care, Architect Health, and Clearlaw. Flourish Care is a maternal health platform aimed at connecting pregnant women to doulas and other services. Architect Health has developed a platform that catalogs, analyzes, and recommends digital health services to health plans and their members. Clearlaw,…

  • iQ3Connect receives Seed investment from Nova Prime Fund

    iQ3Connect, a web-based VR/AR training and collaboration platform, announced on 10/31 a seed round of funding through NOVA Prime Fund. The investment will help iQ3Connect train and empower the future workforce via their 3D platform and metaverse. For the full story click here.

  • NODAR introduces GridDetect for enhanced road safety in autonomous vehicles

    NODAR, a frontrunner in next-generation stereo vision technology for autonomous vehicles, has unveiled a new feature named GridDetect. This advanced capability is a part of NODAR’s existing Hammerhead™ product line. For full story click here.

  • Laurent Pharmaceuticals receives Health Canada approval to initiate Phase 2/3 clinical trial in Long COVID

    Laurent Pharmaceuticals Inc., a Montreal-based biopharmaceutical company, today announced that it has obtained the approval from Health Canada to initiate ESSOR, an adaptive Phase 2/3 randomized placebo-controlled trial testing its oral drug candidate LAU-7b as a potential treatment for Long COVID. For the full story click here.

  • Canada CFIA approves KnipBio Meal as a salmon feed ingredient

    KnipBio is a company that produces fermented microbial proteins to improve the health and taste of farm-raised fish. As of June 8th, Canada’s Food Inspection Agency (CFIA) has approved KnipBio single cell protein meal for inclusion in farmed salmon feeds. Click here to read the full news release.

  • Senzime has entered into an agreement to acquire the US company Respiratory Motion

    Respiratory Motion, a med-tech company dedicated to the development of innovative devices to monitor respiratory variation, has entered into an agreement to be acquired by Senzime. To learn more, read the full news release.

  • Jaia Robotics closes Seed funding round with more than $1 million

    Jaia Robotics, a company that specializes in autonomous underwater vehicles, has surpassed $1 million in seed funding. Click here to read the news full release.

  • Rellevate closed on $4 million round

    Rellevate, Inc., a digital banking & payment services provider today announced that it closed a Series Seed Preferred $4 million round led by Naples Technology Ventures. Click here to see the full release.